Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Regulatory mechanisms of deer antler extracellular vesicles in multilevel tissue repair: a state-of-the-art review

Yuan L., Deng B., Zhang F., Wang D., Chen H.

Narrative Review, published in Front Pharmacol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Pharmacol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41800090
PMCID
PMC12960187
DOI
10.3389/fphar.2026.1758263

Abstract (original English)

Extracellular vesicles (EVs) are defined as key nanoscale messengers that mediate intercellular communication, demonstrating immense potential in tissue repair and regenerative medicine. As the only organ in mammals capable of complete, cyclical regeneration, deer antlers provide EVs with exceptional regenerative bioactivity. This paper systematically reviews and prospectively discusses the research field of deer antler-derived EVs. We first outline their isolation strategies and characteristic functional subtypes, then focus on elucidating their multi-level molecular mechanisms driving tissue repair: at the cellular level, they directly regulate stem cell proliferation and lineage differentiation; at the microenvironmental level, they effectively remodel the immune ecology of injured areas by reprogramming immune cells and coordinating cytokine networks, thereby creating favorable conditions for regeneration. At the molecular level, they precisely regulate core signaling pathways, including the Wnt/β-catenin, NF-κB, miR-21-5p/STAT3, and TGF-β pathways. Finally, this paper prospectively explores cutting-edge developments in the field, including enhancing vesicle targeting and drug-loading capacity through engineering strategies, constructing controlled-release delivery systems based on smart materials, and developing precision therapies tailored to specific pathological microen

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.